Why BofA Sees Strong Upside for Doximity (DOCS)

Group 1 - Doximity (NYSE:DOCS) is identified as a promising mid-cap healthcare stock with a current price target of $82, indicating an 88% upside potential for investors [1] - The growth in Doximity's stock is attributed to increasing healthcare provider (HCP) budgets and a shift from direct-to-consumer (DTC) advertising, alongside digital video initiatives as growth catalysts [2] - Analyst sentiment is positive, with 8 Buy ratings, 5 Hold ratings, and 2 Sell ratings, forecasting a 1-year average price target of $66.62, which represents a 52.6% upside from the current level [3] Group 2 - Doximity operates a digital platform that facilitates online networking for healthcare professionals, covering approximately 80% of U.S.-based physicians, and utilizes AI for HIPAA-compliant communication [4]